Free Malaysia Today8d
This medical innovation treats obesity without surgery
The Allurion swallowable intragastric balloon offers a safe, effective and minimally invasive method of losing weight.
Daisy May Cooper opens up about 10-stone weight loss over three years
Actress Daisy May Cooper has revealed her jaw-dropping 10-stone – or 63.5kg – weight loss over a period of around three years ...
‘Ozempic Butt’ Complaints Rise After Users Discover Unexpected Side Effect
Shortly after the ‘trend’ of taking the diabetes drug Ozempic to lose weight began, many people, including celebrities, ...
The Globe and Mail16d
This Little-Known Stock Just Doubled on Weight-Loss Drug News. Analysts Think It Has 400% Upside Potential From Here.
Allurion Technologies (ALUR) aims to end obesity through innovation. Its flagship Allurion Program features a swallowable, procedure-free intragastric balloon designed to aid weight loss. Coupled with ...
ReShape Lifesciences® Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology
ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company was granted a key international patent from the ...
ReShape Lifesciences Inc: ReShape Lifesciences Granted Key International Patent in Israel for Its Proprietary Diabetes Neuromodulation Technology
ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company ...
Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity
NYSE:ALUR) Allurion Announces Notification of Issuance of New U.S. Patent on Next-Generation Weight Loss Device for the Treatment of Obesity ...
Allurion Announces Plans To Optimize Muscle Mass During GLP-1 Therapy In Combination With the Allurion Program
Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today announced its intention to initiate a clinical study on the combination of the ...